Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2001

View Archived Issues

Primary endpoint achieved in phase III trial of Gilead's adefovir dipivoxil for HBV

Use of PRAC protein in cancer Rx available for licensing from NIH

Licensing opportunity from NIH: new small RNAs as starting point for antibiotic development

Medicure presents drug with potential for healing ischemic injury

Protein Therapeutics begins phase II trial in juvenile RA

Medivir highlights pipeline progress for first half of 2001

Design of mixed direct thrombin and factor Xa inhibitors reported at ISTH

Antiplatelet antibody fragment designed at Chinese university

HTU-PA is a safe and effective thrombolytic agent in acute myocardial infarction

Beneficial effects of humanized anti-hTF antibody in hypercoagulable states

Safer anticoagulation obtained with Ro-67-8698, a new factor VIIa inhibitor, than napsagatran

MabCampath approved in Europe for B-CLL

Lilly Icos seeks European approval of Cialis for treatment of erectile dysfunction

Sea cucumber-based therapy useful for age-associated dementia

EMEA accepts Oxford GlycoSciences' MAA for Vevesca

Cangene halts pilot phase II trial of anti-HCV hyperimmune product

Protective effect demonstrated for FR-167653 against aspirin-induced gastric damage

FTY-720: effects on lymphocytes and in animal models of autoimmune diseases

Ramoplanin granted orphan drug status in Europe

EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin

Antithrombotic pentasaccharide covered extensively at recent scientific meeting

Inhibitors of PDE4 and use in asthma, allergies, etc.

Merck & Co. presents new pyrazinone thrombin inhibitors

Agents for HBV and HIV described in patent literature by Korean lab

Tie2 receptor kinase inhibitors useful for angiogenic disorders

Urotensin II analogues and pharmaceutical compositions for stroke and other disorders

Venlafaxine metabolite ethers with same pharmacological profile as venlafaxine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...